Cargando…

Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production

SARS-CoV-2 contains four structural proteins, two of which, the spike and nucleocapsid, are commonly used for the standardization of novel methods for antibody detection; however, some limitations in their use have been observed due to the homology of this virus with other phylogenetically-related v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortés-Sarabia, Karen, Luna-Pineda, Víctor Manuel, Rodríguez-Ruiz, Hugo Alberto, Leyva-Vázquez, Marco Antonio, Hernández-Sotelo, Daniel, Beltrán-Anaya, Fredy Omar, Vences-Velázquez, Amalia, Del Moral-Hernández, Oscar, Illades-Aguiar, Berenice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442563/ https://www.ncbi.nlm.nih.gov/pubmed/36064951 http://dx.doi.org/10.1038/s41598-022-18517-w

Ejemplares similares

Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
por: Campos-Ruíz, Mario Aldair, et al.
Publicado: (2023)

Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers
por: Cortés-Sarabia, Karen, et al.
Publicado: (2023)

Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers
por: Cortés-Sarabia, Karen, et al.
Publicado: (2023)

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review
por: Cortés-Sarabia, Karen, et al.
Publicado: (2022)

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
por: Rodríguez-Nava, Cynthia, et al.
Publicado: (2023)

Production and characterization of a monoclonal antibody against the sialidase of Gardnerella vaginalis using a synthetic peptide in a MAP8 format
por: Cortés-Sarabia, Karen, et al.
Publicado: (2020)

The E6 Oncoprotein of HPV16 AA-c Variant Regulates Cell Migration through the MINCR/miR-28-5p/RAP1B Axis
por: Perez-Bacho, Eduardo Gil, et al.
Publicado: (2022)

Optimized method for the extraction of contaminant-free IgY antibodies from egg yolk using PEG 6000
por: Madera-Contreras, Andrea Michelle, et al.
Publicado: (2022)

Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer
por: Cortés-Sarabia, Karen, et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer
por: Loaeza-Loaeza, Jaqueline, et al.
Publicado: (2022)

The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population
por: Beltrán-Anaya, Fredy Omar, et al.
Publicado: (2014)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions
por: Torres-Rojas, Francisco Israel, et al.
Publicado: (2018)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions
por: Del Moral-Hernández, Oscar, et al.
Publicado: (2021)

Disposable Device for Bacterial Vaginosis Detection
por: Avila-Huerta, Mariana D., et al.
Publicado: (2023)

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022)

Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients
por: Burbelo, Peter D., et al.
Publicado: (2020)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

One-Step Staining Method for the Identification of Clue Cells and Bacterial Morphotypes Associated with Bacterial Vaginosis
por: Martínez-Figueroa, Carlos, et al.
Publicado: (2022)

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID
por: Brandt, C. T., et al.
Publicado: (2023)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens
por: Favara, D. M., et al.
Publicado: (2020)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
por: Tutukina, Maria, et al.
Publicado: (2021)

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
por: Thomopoulos, Thomas P., et al.
Publicado: (2021)

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Comparison of nucleocapsid and spike antibody ELISAs for determining SARS‐CoV‐2 seropositivity in Kenyan women and infants
por: Fish, Carolyn S., et al.
Publicado: (2022)

Prevalence and Distribution of Human Papillomavirus Genotypes (1997–2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico
por: Alarcón-Romero, Luz del Carmen, et al.
Publicado: (2022)

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
por: Schuler, Charles F., et al.
Publicado: (2021)

Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles
por: Soares, Sinei Ramos, et al.
Publicado: (2023)

Tracking hantavirus nucleocapsid protein using intracellular antibodies
por: Li, Jiandong, et al.
Publicado: (2010)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19
por: Flinck, Heini, et al.
Publicado: (2021)

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2020)

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
por: Liu, Wanbing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tqnha11cqsa338vvc59arfmsna